Understanding Mitral Regurgitation
Mitral regurgitation occurs when the mitral valve fails to coapt properly during left ventricular systole, allowing blood to flow retrograde into the left atrium. This creates a volume overload state where the left ventricle must accommodate both systemic venous return and the regurgitant fraction each cardiac cycle. Over time, eccentric hypertrophy and chamber dilation develop as compensatory mechanisms.
Regurgitant severity ranges from trace (clinically insignificant) to massive (requiring urgent intervention). The pathophysiological consequence depends on both the lesion orifice area and the driving pressure gradient across the incompetent valve. Acute severe regurgitation may precipitate flash pulmonary edema and haemodynamic collapse, whereas chronic lesions often remain asymptomatic until late-stage decompensation occurs.
Primary (organic) mitral regurgitation stems from valve apparatus pathology—endocarditis, rheumatic damage, degenerative prolapse, or connective tissue disease. Secondary (functional) regurgitation arises from left ventricular dilation and annular enlargement without intrinsic valve disease, commonly following myocardial infarction or non-ischaemic cardiomyopathy.
EROA Calculation Method
The effective regurgitant orifice area quantifies the anatomical lesion size using continuous-wave doppler and PISA measurement. This approach provides superior reproducibility compared with qualitative colour-flow imaging and integrates haemodynamic principles into a single numeric parameter.
The calculation proceeds in two steps: first, volume flow rate through the PISA surface, then division by peak regurgitant velocity to yield orifice area.
VFR = 2π × r² × Va
EROA = VFR ÷ Vmax
Regurgitant Volume = EROA × VTI
r— Radius of the proximal isovelocity surface area hemisphere, measured in centimetres from the colour-flow reversal point to the valve orificeVa— Aliasing velocity (nyquist limit), typically 50–60 cm/s on standard settings, at which the colour map wraps from blue to redVmax— Peak continuous-wave doppler velocity of the regurgitant jet, measured in centimetres per secondVTI— Velocity time integral of the regurgitant jet envelope, obtained by planimetry of the continuous-wave spectral displayVFR— Volume flow rate across the PISA surface in millilitres per second
ECHO Acquisition and Measurement Technique
Accurate EROA determination requires meticulous echocardiographic technique. Standardised apical windows—four-chamber, two-chamber, and long-axis views—permit optimal alignment of continuous-wave doppler parallel to regurgitant jet flow. Deviation from parallel incidence introduces cosine error and systematically underestimates velocity.
PISA radius measurement demands colour-flow optimisation. Reduce the nyquist limit until a clear aliasing boundary appears just proximal to the mitral orifice; avoid excessive colour gain, which obscures the reversal zone. Measurement at end-systole minimises variability, though some operators measure at the point of maximum radius.
Continuous-wave tracings should display a full spectral envelope with distinct borders. Incomplete or serrated boundaries suggest suboptimal beam alignment. Multiple cardiac cycles should be averaged, and at least three measurements per parameter should be recorded to account for beat-to-beat variation, particularly in atrial fibrillation.
Validation against surgical or catheterisation data confirms EROA reliability in moderate-to-severe lesions; however, in mild regurgitation, acoustic dropout and measurement noise produce wide confidence intervals.
Common Pitfalls and Caveats
Echocardiographic measurement errors propagate significantly through EROA formulae, particularly the PISA radius which is squared in the volume flow calculation.
- Radius measurement variability — The PISA radius must be perpendicular to the regurgitant jet axis. Off-axis measurement or inclusion of colour aliasing artefacts inflates the radius squared term, potentially doubling calculated EROA. Always acquire multiple diameter measurements in orthogonal planes and average them.
- Regurgitant jet geometry assumptions — The calculation assumes a hemispherical PISA surface. Eccentric jets or wall-constraining regurgitation violate this assumption and yield overestimated EROA values. Three-dimensional echocardiography may improve accuracy in these complex anatomies.
- Timing and loading conditions — Regurgitant severity fluctuates with heart rate, blood pressure, and contractility. Measurements obtained during hypotension or poor contractile function underestimate true lesion severity. Repeat assessment under standardised loading conditions when haemodynamics are stable.
- Coexistent valvular disease — Aortic regurgitation or mitral stenosis alters doppler profiles and invalidates single-orifice assumptions. Comprehensive assessment of all four cardiac valves is essential before assigning EROA-based severity grades.
Severity Grading and Clinical Integration
The 2014 ACC/AHA guidelines stratify mitral regurgitation into stages incorporating symptoms, structural valve changes, and quantitative indices including EROA. Asymptomatic primary regurgitation is classified as severe if EROA exceeds 40 mm² or regurgitant volume surpasses 60 mL per beat. Symptomatic lesions are automatically categorised as severe regardless of quantitative values, reflecting the clinical principle that symptom burden mandates intervention.
Secondary (functional) regurgitation follows a separate pathway; mild-to-moderate lesions are conservatively managed with heart failure medications, whereas severe secondary regurgitation with EROA >20 mm² may warrant combined mitral valve and left ventricular remodelling procedures.
Serial echocardiography at 6–12 month intervals provides progression rate and identifies inflection points where medical therapy yields to surgical consideration. Watchful observation remains appropriate for asymptomatic primary lesions with EROA 20–40 mm²; however, repeat imaging is mandatory for borderline values or if symptoms emerge between scheduled assessments.